Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2)
ObjectiveTo optimize the construction of pharmaceutical services in medical institutions, advance the development of clinical pharmacy as a discipline, enhance the level of clinical pharmacy services, systematically implement and evaluate clinical pharmacy practices, and improve patient therapeutic...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2024.1472355/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841540128465485824 |
|---|---|
| author | Liuyun Wu Ziyan Lv Min Chen Xingyue Zheng Lian Li Shan Du Lizhu Han Qinan Yin Yin Wang Xinxia Liu Wenyuan Li Xuefei Huang Hulin Wang Xiaoqing Yi Xiaojiao Cui Zhujun Chen Yueyuan Wang Yingying Hou Xi Zheng Yang Lei Mengqiu Gou Yue Wu Fengjiao Kang Fengqun Cai Shuhong Liang Yong Yang Jinqi Li Yuan Bian |
| author_facet | Liuyun Wu Ziyan Lv Min Chen Xingyue Zheng Lian Li Shan Du Lizhu Han Qinan Yin Yin Wang Xinxia Liu Wenyuan Li Xuefei Huang Hulin Wang Xiaoqing Yi Xiaojiao Cui Zhujun Chen Yueyuan Wang Yingying Hou Xi Zheng Yang Lei Mengqiu Gou Yue Wu Fengjiao Kang Fengqun Cai Shuhong Liang Yong Yang Jinqi Li Yuan Bian |
| author_sort | Liuyun Wu |
| collection | DOAJ |
| description | ObjectiveTo optimize the construction of pharmaceutical services in medical institutions, advance the development of clinical pharmacy as a discipline, enhance the level of clinical pharmacy services, systematically implement and evaluate clinical pharmacy practices, and improve patient therapeutic outcomes, we have developed the Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (Version 2).MethodsThis guideline was designed following the World Health Organization (WHO) Guideline Development Manual. The Delphi method was employed to identify clinical questions. A comprehensive systematic search was conducted to collect existing evidence on relevant issues, and the systematic reviews, evidence grading, and evidence summaries were subsequently compiled. The guideline employs the Joanna Briggs Institute (JBI) evidence level system from Australia and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system introduced by WHO in 2004 to classify the quality of evidence. Consensus on the recommendations and evidence levels was achieved through the Delphi method, resulting in the formation of the Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (Version 2).ResultsThrough a questionnaire survey of over 100 experts and the Delphi method voting, 23 preliminary indicators for evaluating the value of clinical pharmacy services were identified. The content of these included indicators was searched according to the PICO principle, followed by systematic reviews, meta-analyses, network meta-analyses, and related original research. Each search strategy was reviewed and approved by the guidelines steering committee. Ultimately, three dimensions for evaluating the value of clinical pharmacy were identified, encompassing 15 indicators, resulting in 20 recommendations.ConclusionThis guideline presents a set of metrics to assess the quality and effectiveness of clinical pharmacy services, which is crucial for enhancing and elevating clinical pharmacy services in healthcare institutions.Systematic review registrationhttp://www.guidelines-registry.org/guide/28502a74-7038-439c-bdee-d355747e2a9d, identifier: PREPARE-2022CN756. |
| format | Article |
| id | doaj-art-83e9278e303b42b9bda0d58acc43a483 |
| institution | Kabale University |
| issn | 2296-2565 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Public Health |
| spelling | doaj-art-83e9278e303b42b9bda0d58acc43a4832025-01-14T06:10:45ZengFrontiers Media S.A.Frontiers in Public Health2296-25652025-01-011210.3389/fpubh.2024.14723551472355Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2)Liuyun Wu0Ziyan Lv1Min Chen2Xingyue Zheng3Lian Li4Shan Du5Lizhu Han6Qinan Yin7Yin Wang8Xinxia Liu9Wenyuan Li10Xuefei Huang11Hulin Wang12Xiaoqing Yi13Xiaojiao Cui14Zhujun Chen15Yueyuan Wang16Yingying Hou17Xi Zheng18Yang Lei19Mengqiu Gou20Yue Wu21Fengjiao Kang22Fengqun Cai23Shuhong Liang24Yong Yang25Jinqi Li26Yuan Bian27Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, The Fourth People's Hospital of Chengdu, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaObjectiveTo optimize the construction of pharmaceutical services in medical institutions, advance the development of clinical pharmacy as a discipline, enhance the level of clinical pharmacy services, systematically implement and evaluate clinical pharmacy practices, and improve patient therapeutic outcomes, we have developed the Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (Version 2).MethodsThis guideline was designed following the World Health Organization (WHO) Guideline Development Manual. The Delphi method was employed to identify clinical questions. A comprehensive systematic search was conducted to collect existing evidence on relevant issues, and the systematic reviews, evidence grading, and evidence summaries were subsequently compiled. The guideline employs the Joanna Briggs Institute (JBI) evidence level system from Australia and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system introduced by WHO in 2004 to classify the quality of evidence. Consensus on the recommendations and evidence levels was achieved through the Delphi method, resulting in the formation of the Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (Version 2).ResultsThrough a questionnaire survey of over 100 experts and the Delphi method voting, 23 preliminary indicators for evaluating the value of clinical pharmacy services were identified. The content of these included indicators was searched according to the PICO principle, followed by systematic reviews, meta-analyses, network meta-analyses, and related original research. Each search strategy was reviewed and approved by the guidelines steering committee. Ultimately, three dimensions for evaluating the value of clinical pharmacy were identified, encompassing 15 indicators, resulting in 20 recommendations.ConclusionThis guideline presents a set of metrics to assess the quality and effectiveness of clinical pharmacy services, which is crucial for enhancing and elevating clinical pharmacy services in healthcare institutions.Systematic review registrationhttp://www.guidelines-registry.org/guide/28502a74-7038-439c-bdee-d355747e2a9d, identifier: PREPARE-2022CN756.https://www.frontiersin.org/articles/10.3389/fpubh.2024.1472355/fullclinical pharmacypharmaceutical servicespharmaceutical practicevalue evaluationguidelinesquality management |
| spellingShingle | Liuyun Wu Ziyan Lv Min Chen Xingyue Zheng Lian Li Shan Du Lizhu Han Qinan Yin Yin Wang Xinxia Liu Wenyuan Li Xuefei Huang Hulin Wang Xiaoqing Yi Xiaojiao Cui Zhujun Chen Yueyuan Wang Yingying Hou Xi Zheng Yang Lei Mengqiu Gou Yue Wu Fengjiao Kang Fengqun Cai Shuhong Liang Yong Yang Jinqi Li Yuan Bian Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2) Frontiers in Public Health clinical pharmacy pharmaceutical services pharmaceutical practice value evaluation guidelines quality management |
| title | Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2) |
| title_full | Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2) |
| title_fullStr | Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2) |
| title_full_unstemmed | Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2) |
| title_short | Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2) |
| title_sort | practice guidelines for the value evaluation of clinical pharmacy services version 2 |
| topic | clinical pharmacy pharmaceutical services pharmaceutical practice value evaluation guidelines quality management |
| url | https://www.frontiersin.org/articles/10.3389/fpubh.2024.1472355/full |
| work_keys_str_mv | AT liuyunwu practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT ziyanlv practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT minchen practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT xingyuezheng practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT lianli practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT shandu practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT lizhuhan practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT qinanyin practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT yinwang practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT xinxialiu practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT wenyuanli practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT xuefeihuang practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT hulinwang practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT xiaoqingyi practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT xiaojiaocui practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT zhujunchen practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT yueyuanwang practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT yingyinghou practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT xizheng practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT yanglei practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT mengqiugou practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT yuewu practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT fengjiaokang practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT fengquncai practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT shuhongliang practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT yongyang practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT jinqili practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 AT yuanbian practiceguidelinesforthevalueevaluationofclinicalpharmacyservicesversion2 |